Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.
UFP Technologies Inc. reports developments for a contract development and manufacturing organization focused on single-use and single-patient medical devices. Company news commonly covers quarterly and annual results, non-GAAP measures such as adjusted EBITDA and adjusted EPS, program ramps, backlog commentary, acquisition integration, and manufacturing capacity tied to medical-device customers.
Updates also include customer supply agreements, new program launches, investor conference participation, and governance matters such as executive succession planning. The company's products and components are used across medical device, wound care, infection prevention, minimally invasive surgery, wearable, orthopedic soft-goods, and orthopedic implant-packaging applications.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
UFP Technologies, Inc. (Nasdaq: UFPT), a leader in custom manufacturing for medical devices and packaging, will present at the Sidoti Virtual Investor Conference on March 22-23, 2023. The presentation will start at 8:30 A.M. ET on March 22, accessible via Sidoti's website and UFP's investor relations page. The company will also conduct one-on-one meetings with investors on the same day. Registration is free and open to all. UFP Technologies specializes in solutions using foams, films, and plastics to create highly engineered products.
UFP Technologies, Inc. (Nasdaq: UFPT) reported significant financial growth for the year ending December 31, 2022, with a net income of $41.8 million ($5.45 per share), up from $15.9 million ($2.09 per share) in 2021. Total sales reached $353.8 million, a 71.5% increase compared to $206.3 million the previous year. The fourth quarter net income also rose to $8.5 million from $3.2 million year-over-year. Notably, sales to the medical market surged 116.0%, contributing to overall organic growth of 18.6%. The company successfully integrated multiple acquisitions and maintained a strong balance sheet with approximately $55 million in debt.
UFP Technologies, Inc. (Nasdaq: UFPT) announced participation in the Southwest IDEAS Investor Conference on November 16, 2022. Chairman & CEO R. Jeffrey Bailly and CFO Ron Lataille will present at 3:00 pm CT. The presentation will be accessible via webcast on the conference site and the company’s investor relations page.
The IDEAS Conferences aim to provide quality companies with a platform to showcase their investment potential to an influential audience of investment professionals. The conferences are held annually in Boston, Chicago, and Dallas.
UFP Technologies, Inc. (Nasdaq: UFPT) reported significant financial growth in its Q3 2022 results. Net income surged to $19.5 million ($2.56 per diluted share), up from $3.8 million ($0.50 per share) in Q3 2021. Sales increased by 91% to $97 million, driven primarily by the medical market, which saw a 152% increase. Year-to-date sales reached $262.6 million, a 75% increase from the previous year. Notably, gross margins improved to 26.3%, up 260 basis points from the prior year.